Home › Funds › Alphabet Inc. › RVMD
Alphabet Inc. position in RVMD
REVOLUTION MEDICINES INC · Health Care
Alphabet Inc. reported holding 2,673,909 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$548.8M, representing 0.62% of its reported portfolio and ranking #5 among its reported holdings. Alphabet Inc. has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Alphabet Inc.'s RVMD position evolved
Alphabet Inc. first disclosed a stake in RVMD in Q4 2023 at 5,301,512 shares (US$152.0M). The position peaked in Q2 2026 at 2,946,619 shares, worth US$551.8M. Across 12 filings, Alphabet Inc. increased the stake 0 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,673,909 shares valued at US$548.8M — a reduction of -272,710 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 5.30M | $152.05M | New |
| Q1 2024 | 5.30M | $170.87M | Hold |
| Q2 2024 | 5.31M | $205.97M | Hold |
| Q3 2024 | 4.26M | $193.02M | Reduce |
| Q4 2024 | 4.13M | $180.79M | Reduce |
| Q1 2025 | 4.13M | $146.15M | Hold |
| Q2 2025 | 4.13M | $152.06M | Hold |
| Q3 2025 | 4.13M | $193.02M | Hold |
| Q4 2025 | 3.35M | $266.44M | Reduce |
| Q1 2026 | 3.29M | $320.20M | Reduce |
| Q2 2026 | 2.95M | $551.84M | Reduce |
| Q3 2026 | 2.67M | $548.85M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 57 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $1.19B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.30M sh · $430.18M · Q2 2026
- Nearwater Capital Markets, Ltd 2.10M sh · $392.73M · Q2 2026
More on Alphabet Inc.
FAQ
How long has Alphabet Inc. held RVMD?
Alphabet Inc. has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Alphabet Inc.'s current position in RVMD?
As of Q3 2026, Alphabet Inc. holds 2.67M shares of RVMD (REVOLUTION MEDICINES INC), valued at $548.85M, representing 0.62% of its reported portfolio and ranking #5.
Has Alphabet Inc. been buying or selling RVMD?
In the latest 13F filing (Q3 2026), Alphabet Inc. reduced its position in RVMD. The position peaked in Q2 2026 at 2.95M shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.